Dementia Clinical Trials

Find Dementia Clinical Trials Near You

Deciphering the Factors of Longevity Through a Multi-Omics Study in Long-Lived Individuals in Hong Kong

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

Population aging is changing societal dynamics and poses significant global challenges. By 2050, an estimated 1.6 billion people worldwide will be over age 65. Because aging is the primary risk factor for many common chronic diseases, it is essential to reduce the burden of age-related illnesses and promote healthy aging. Hong Kong has one of the largest proportions of elderly adults and has the highest life expectancy in the world, with approximately 11,575 centenarians reported in 2021. Thus, the long-lived population in Hong Kong is a valuable resource for studying healthy aging. Longevity is a complex trait influenced by genetic, environmental, and behavioral factors. To unveil the mechanisms leading to longevity and healthy aging, researchers focused on centenarians who are extremely long living. Comparisons between long-lived individuals (LLIs) and others have identified several genetic factors and protein markers associated with longevity. Previous centenarian studies revealed that centenarians and their offsprings have a 5-fold lower risk of developing age-related diseases such as Alzheimer's disease and higher cognitive reserve. Certain protein signatures predict longer survival and centenarians acquire aging signatures much later than elderly in the general population. Certain healthy lifestyle leads to higher chance becoming centenarians, including never smoking, exercise and greater dietary diversity. Despite emerging studies on centenarian population, an integrated approach to understand diverse molecular signatures of longevity is still lacking. Moreover, most of the centenarian studies are based on European descents. To conclude, a multi-omics study examining the genetic, proteomic, metabolomic, and microbiota profiles of LLIs in Chinese population is necessary. Hence, the study proposed herein aims to identify multi-omics biomarkers that can be used to monitor aging processes and related diseases. In addition, it will provide candidate modifiable factors to promote healthy aging, focusing on Chinese population and local Hong Kong population for the first time. Ultimately, the insights gained from this research will inform the development of effective strategies to enhance healthy aging and improve the quality of life of our local aging population.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 65
Healthy Volunteers: t
View:

• Han Chinese ethnicity

• Able to provide official evidence for being 95 years or older (e.g., a birth certificate)

• Mentally capable of consenting to join the study with or without informant presence

• Consent to donation of biospecimens (i.e., blood)

Locations
Other Locations
China
Hong Kong University of Science and Technology
RECRUITING
Hong Kong
Contact Information
Primary
Nancy Ip, PhD
boip@ust.hk
+852-23587304
Backup
Hiu Yi Wong, PhD
annawong@ust.hk
+852-23587344
Time Frame
Start Date: 2026-03-01
Estimated Completion Date: 2031-02-28
Participants
Target number of participants: 2500
Treatments
long-lived individuals (LLIs)
individuals aged 95 years or older
Elderly controls
elderly people aged 65-94 years
Related Therapeutic Areas
Sponsors
Collaborators: Hong Kong Center for Neurodegenerative Diseases
Leads: Hong Kong University of Science and Technology

This content was sourced from clinicaltrials.gov